BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal
SEC Notifies ImClone It May Bring Action Against Company
Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study
NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC
NRSAs Renamed For Kirschstein.
Trending Stories
- Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - VCU’s Baskin and UNC’s Ferris weigh oncology’s looming dilemma—MCDs
Center directors are strategizing for likely FDA approval of GRAIL’s Galleri - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- As trust in USPSTF erodes, cancer screening is in peril
David Ransohoff predicts a “Wild West” era without evidence-based screening guidelines









